| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 702.70 | 6.5% | 16.6% |
| Total Income | 726.70 | 6.2% | 15.6% |
| Expenditure | 566.60 | 7.0% | 19.3% |
| PBT | 160.10 | 28.8% | 4.4% |
| Net Profit | 132.20 | 44.6% | 15.0% |
| OPM | 26.58% | 3.97pp | 1.47pp |
| NPM | 18.19% | 4.83pp | 6.56pp |
| EPS | 7.86 | 45.0% | 57.7% |
Dr. Lal PathLabs Approves FY26 Results, ₹4 Dividend, Acquires SDCPL
30 Apr 2026 · 30 Apr, 3:34 pm
Summary
Dr. Lal PathLabs Ltd. reported financial updates for Q4 & FY26.
Informational and educational content only. Not investment advice.